A PHASE 2A, MULTICENTER, OPEN-LABEL STUDY OF RVT-1401 FOR THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ACTIVE GRAVES' OPHTHALMOPATHY

Registry ID
RVT-1401-1002
Source registry
HEALTH_CANADA
Status
Ongoing
Phase
PHASE2
Study type
INTERVENTIONAL
Sponsor
IMMUNOVANT SCIENCES GMBH
Start date
2019-03-01
Last update
2019-01-14

Conditions

View on source registry